Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
M. Nilsson, Lg. Lundh, Å. Westrin & S. Westling. (2021) Executive functioning in psychiatric patients with deliberate self-harm, as compared with a psychiatric and a healthy comparison group. Journal of Clinical and Experimental Neuropsychology 43:3, pages 225-237.
Read now
Read now
Articles from other publishers (65)
Dieter Riemann, Colin A. Espie, Ellemarije Altena, Erna Sif Arnardottir, Chiara Baglioni, Claudio L. A. Bassetti, Celyne Bastien, Natalija Berzina, Bjørn Bjorvatn, Dimitris Dikeos, Leja Dolenc Groselj, Jason G. Ellis, Diego Garcia‐Borreguero, Pierre A. Geoffroy, Michaela Gjerstad, Marta Gonçalves, Elisabeth Hertenstein, Kerstin Hoedlmoser, Tuuliki Hion, Brigitte Holzinger, Karolina Janku, Markus Jansson‐Fröjmark, Heli Järnefelt, Susanna Jernelöv, Poul Jørgen Jennum, Samson Khachatryan, Lukas Krone, Simon D. Kyle, Jaap Lancee, Damien Leger, Adrian Lupusor, Daniel Ruivo Marques, Christoph Nissen, Laura Palagini, Tiina Paunio, Lampros Perogamvros, Dirk Pevernagie, Manuel Schabus, Tamar Shochat, Andras Szentkiralyi, Eus Van Someren, Annemieke van Straten, Adam Wichniak, Johan Verbraecken & Kai Spiegelhalder. (2023) The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. Journal of Sleep Research 32:6.
Crossref
Crossref
Martin Broberg, Viola Helaakoski, Tuomo Kiiskinen, Tiina Paunio, Samuel E Jones, Nina Mars, Jacqueline M Lane, Richa Saxena & Hanna M Ollila. (2023) Genetics of sleep medication purchases suggests causality from sleep problems to psychiatric traits. SLEEP.
Crossref
Crossref
Mingjin Zhu, Guoyua Pan, Fang Luo, Shuyan Sui & Yonghua Zhang. (2023) Modified Suanzaoren decoction in treating post-stroke cognitive impairment with comorbid insomnia symptoms: A clinical trial. Medicine 102:40, pages e35239.
Crossref
Crossref
Mengzhen Zhou & Yanran Li. (2023) Effect of different doses of almorexant on learning and memory in 8-month-old APP/PS1 (AD) mice. Peptides 167, pages 171044.
Crossref
Crossref
Greg J. Elder, Ellemarije Altena, Laura Palagini & Jason G. Ellis. (2023)
Stress and the hypothalamic–pituitary–adrenal axis: How can the
COVID
‐19 pandemic inform our understanding and treatment of acute insomnia?
. Journal of Sleep Research 32:4.
Crossref
Crossref
Marco Kramer, Bianca Ueberberg, Barbara Emons, Julia Göbel-Erkan, Georg Juckel & Ida Sibylle Haussleiter. (2023) Prescription of Sedative Hypnotics in Psychiatric and Somatic Inpatients. GeroPsych.
Crossref
Crossref
Kazumaro Okino, Hirohisa Suzuki, Hiroi Tomioka, Kenji Sanada, Keita Kawai, Akira Iwanami & Atsuko Inamoto. (2023) Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant. Human Psychopharmacology: Clinical and Experimental 38:3.
Crossref
Crossref
Margaret Moline, Shoji Asakura, Carsten Beuckman, Ishani Landry, Beatrice Setnik, Judy Ashworth & Jack E. Henningfield. (2023) The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act. Psychopharmacology 240:4, pages 699-711.
Crossref
Crossref
Mengzhen Zhou, Jiyou Tang, Shasha Li, Yaran Li & Mengke Zhao. (2023) Orexin dual receptor antagonists, zolpidem, zopiclone, eszopiclone, and cognitive research: A comprehensive dose-response meta-analysis. Frontiers in Human Neuroscience 16.
Crossref
Crossref
Sara E. Alger, Emily Stekl, Sidney Allotey-Addo, Grace Klosterman & Thomas J. Balkin. 2023. Encyclopedia of Sleep and Circadian Rhythms. Encyclopedia of Sleep and Circadian Rhythms
506
517
.
Simone Campagnari, Lorenzo Zamboni, Francesca Fusina, Rebecca Casari & Fabio Lugoboni. (2022) Case Report: High doses of Zolpidem and QT interval lengthening: Is there a relationship? A case series. Frontiers in Psychiatry 13.
Crossref
Crossref
Christopher N. Kaufmann, Adam P. Spira, Emerson M. Wickwire, Ramin Mojtabai, Sonia Ancoli-Israel, Constance H. Fung & Atul Malhotra. (2022) Declining trend in use of medications for sleep disturbance in the United States from 2013 to 2018. Journal of Clinical Sleep Medicine 18:10, pages 2459-2465.
Crossref
Crossref
M.J. Norberto, L. Rodríguez-Santos, J. Montanero & M.C. Cáceres. (2022) Concordance in psychopharmacological treatment before and after first mental health consultation. Archives of Psychiatric Nursing 39, pages 66-72.
Crossref
Crossref
Kunihiro Iwamoto, Mari Iwata, Daiji Kambe, Yumiko Imadera, Naoki Tachibana, Yu Kajiyama, Masahiko Ando & Norio Ozaki. (2022) Residual effects of zopiclone on driving performance using a standardized driving simulator among healthy volunteers. Psychopharmacology 239:3, pages 841-850.
Crossref
Crossref
Charli Sargent, Michele Lastella, Stephen Schwerdt & Gregory D. Roach. (2021) An Individualized Intervention Increases Sleep Duration in Professional Athletes. Journal of Strength and Conditioning Research 35:12, pages 3407-3413.
Crossref
Crossref
Olivia L. Sawdon, Greg J. Elder, Nayantara Santhi, Pamela Alfonso-Miller & Jason G. Ellis. (2021) Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic in self-reported good and poor sleepers (Sleep COVID-19): study protocol for a randomised controlled trial. Trials 22:1.
Crossref
Crossref
Joshua H. Cho, Stephanie Kremer & Jeffrey Young. (2021) Who to Refer to a Behavioral Insomnia Clinic? — Recommendations Based on Treatment Rationale and Response Prediction. Current Sleep Medicine Reports 7:4, pages 213-220.
Crossref
Crossref
Guilherme Tavares, Gizela Kelmann, Francisco Tustumi, Catherine Nardini Tundisi, Bárbara Regina Bruço Silveira, Bruno Maximiliano Augusto Colombo Barbosa, Diana Bragança Winther, Eduarda Conte Boutros, Gabriel dos Santos Villar, Giovanna Brunocilla, Gustavo Rodrigues Caldas Lourenção, Jiulia Giovanna Aranha Ferreira & Wanderley Marques Bernardo. (2021) Cognitive and balance dysfunctions due to the use of zolpidem in the elderly: a systematic review. Dementia & Neuropsychologia 15:3, pages 396-404.
Crossref
Crossref
Lijun Liu, Xiaozhen Lv, Shuzhe Zhou, Qi Liu, Jing Wang, Hongjun Tian, Kerang Zhang, Jing Wei, Chuanyue Wang, Qiaoling Chen, Gang Zhu, Xueyi Wang, Nan Zhang, Yu Huang, Tianmei Si & Xin Yu. (2021) The effect of selective serotonin reuptake inhibitors on cognitive impairment in patients with depression: A prospective, multicenter, observational study. Journal of Psychiatric Research 141, pages 26-33.
Crossref
Crossref
Dominique Chao, Andrew Hale, N. Lynn Henry, Anna L. Kratz & Nicolette M. Gabel. (2021) Cancer-Related Cognitive Impairment or “Chemobrain:” Emerging Assessments, Treatments, and Targets for Intervention. Current Physical Medicine and Rehabilitation Reports 9:3, pages 108-118.
Crossref
Crossref
Amber N. Edinoff, Natalie Wu, Yahya T. Ghaffar, Rosemary Prejean, Rachel Gremillion, Mark Cogburn, Azem A. Chami, Adam M. Kaye & Alan D. Kaye. (2021) Zolpidem: Efficacy and Side Effects for Insomnia. Health Psychology Research 9:1.
Crossref
Crossref
Wonjeong Jeong, Jae Hong Joo, Hyunkyu Kim, Yun Kyung Kim, Eun-Cheol Park & Sung-In Jang. (2021) Association Between the Use of Hypnotics and the Risk of Alzheimer’s Disease. Journal of Alzheimer's Disease 81:4, pages 1381-1389.
Crossref
Crossref
Bo-Ram Yang, Kyu-Nam Heo, Yun Mi Yu, Ga-Bin Yeom, Hye Duck Choi, Ju-Yeun Lee & Young-Mi Ah. (2021) Interrupted Time Series Analysis of Changes in Zolpidem Use Due to Media Broadcasts. International Journal of Environmental Research and Public Health 18:10, pages 5114.
Crossref
Crossref
Liridona Gashi, Willy Pedersen & Thomas Ugelvik. (2019) The pains of detainment: Experience of time and coping strategies at immigration detention centres. Theoretical Criminology 25:1, pages 88-106.
Crossref
Crossref
Catherine A. McCall & Nathaniel F. Watson. 2021. Handbook of the Psychology of Aging. Handbook of the Psychology of Aging
99
117
.
I. V. Oleichik, T. I. Shishkovskaia & P. A. Baranov. (2020) Contemporary approaches to correction of cognitive impairment in endogenous depression. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY:4, pages 82-93.
Crossref
Crossref
Simon J. C. Davies. 2020. Seminars in Clinical Psychopharmacology. Seminars in Clinical Psychopharmacology
543
576
.
Yeon-Hee Baek, Hye-Jun Kim, Ji-Hwan Bae, Hyesung Lee, In-Sun Oh, Woo Jung Kim & Ju-Young Shin. (2020) Benzodiazepine-Related Cognitive Impairment or Dementia: A Signal Detection Study Using a Case/Non-Case Approach. Psychiatry Investigation 17:6, pages 587-595.
Crossref
Crossref
Merete OslerMartin Balslev Jørgensen. (2020) Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders: A Nationwide Cohort and Nested Case-Control Study. American Journal of Psychiatry 177:6, pages 497-505.
Crossref
Crossref
Yeon-Hee Baek, Hyesung Lee, Woo Jung Kim, Jee-Eun Chung, Nicole Pratt, Lisa Kalisch Ellett & Ju-Young Shin. (2020) Uncertain Association Between Benzodiazepine Use and the Risk of Dementia: A Cohort Study. Journal of the American Medical Directors Association 21:2, pages 201-211.e2.
Crossref
Crossref
Jussi Valtonen & Mira Karrasch. (2020) Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case report. Therapeutic Advances in Psychopharmacology 10, pages 204512532090573.
Crossref
Crossref
Nader H. Moniri. (2019) Reintroduction of quazepam. International Clinical Psychopharmacology 34:6, pages 275-285.
Crossref
Crossref
Kristoffer Bothelius, Eva-Britt Hysing, Tove Filén, Linnea Lundeborg & Torsten Gordh. (2019) Insomnia-related Memory Impairment in Individuals With Very Complex Chronic Pain. Cognitive and Behavioral Neurology 32:3, pages 164-171.
Crossref
Crossref
Amélie Rochefort, Denise C. Jarrin, Lynda Bélanger, Hans Ivers & Charles M. Morin. (2019) Insomnia treatment response as a function of objectively measured sleep duration. Sleep Medicine 56, pages 135-144.
Crossref
Crossref
David John Wright, Sion Scott, Jackie Buck & Debi Bhattacharya. (2019) Role of nurses in supporting proactive deprescribing. Nursing Standard 34:3, pages 44-50.
Crossref
Crossref
Matthew D. Krasowski. 2019. Critical Issues in Alcohol and Drugs of Abuse Testing. Critical Issues in Alcohol and Drugs of Abuse Testing
225
236
.
Wolfgang Gaebel, Alkomiet Hasan & Peter Falkai. 2019. S3-Leitlinie Schizophrenie. S3-Leitlinie Schizophrenie
51
137
.
Andrea Lawson, Roohie Parmar & Eileen P. Sloan. 2019. Perinatal Psychopharmacology. Perinatal Psychopharmacology
341
376
.
Natalia M. Jasiak-Panek, Kevin T. Le, Thomas Moran & Sukhraj Mudahar. 2019. Allergy and Sleep. Allergy and Sleep
385
407
.
Kyung-Rock Park, Kyu-Beom Kim, Yeon-Hee Baek, Hi Gin Sung, Jung-Tae Park, Eui-Kyung Lee & Ju-Young Shin. (2018) Signal detection of benzodiazepine use and risk of dementia: sequence symmetry analysis using South Korean national healthcare database. International Journal of Clinical Pharmacy 40:6, pages 1568-1576.
Crossref
Crossref
Simon F Crowe & Elizabeth K Stranks. (2018) The Residual Medium and Long-term Cognitive Effects of Benzodiazepine Use: An Updated Meta-analysis. Archives of Clinical Neuropsychology 33:7, pages 901-911.
Crossref
Crossref
Shi-Bin Li, Natalie Nevárez, William J Giardino & Luis de Lecea. (2018) Optical probing of orexin/hypocretin receptor antagonists. Sleep 41:10.
Crossref
Crossref
Víviam Vargas Barros, Emérita Sátiro Opaleye, Marcelo Demarzo, Sarah Bowen, Daniela Fernández Curado, Helena Hachul & Ana Regina Noto. (2018) Dispositional mindfulness, anticipation and abstinence symptoms related to hypnotic dependence among insomniac women who seek treatment: A cross-sectional study. PLOS ONE 13:3, pages e0194035.
Crossref
Crossref
. 2018. Sedation. Sedation
95
119
.
Johannes Pantel. 2018. Psychotherapie mit Älteren bei Sucht und komorbiden Störungen. Psychotherapie mit Älteren bei Sucht und komorbiden Störungen
139
157
.
Joseph Cerasuolo & Anthony Izzo. (2017) Persistent impairment in working memory following severe hyperglycemia in newly diagnosed type 2 diabetes. Endocrinology, Diabetes & Metabolism Case Reports.
Crossref
Crossref
Dieter Riemann, Chiara Baglioni, Claudio Bassetti, Bjørn Bjorvatn, Leja Dolenc Groselj, Jason G. Ellis, Colin A. Espie, Diego Garcia-Borreguero, Michaela Gjerstad, Marta Gonçalves, Elisabeth Hertenstein, Markus Jansson-Fröjmark, Poul J. Jennum, Damien Leger, Christoph Nissen, Liborio Parrino, Tiina Paunio, Dirk Pevernagie, Johan Verbraecken, Hans-Günter Weeß, Adam Wichniak, Irina Zavalko, Erna S. Arnardottir, Oana-Claudia Deleanu, Barbara Strazisar, Marielle Zoetmulder & Kai Spiegelhalder. (2017) European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research 26:6, pages 675-700.
Crossref
Crossref
Taro Kishi, Ken Inada, Yuki Matsui & Nakao Iwata. (2017) Z-drug for schizophrenia: A systematic review and meta-analysis. Psychiatry Research 256, pages 365-370.
Crossref
Crossref
Alicia Nevriana, Jette Möller, Lucie Laflamme & Joel Monárrez-Espino. (2017) New, Occasional, and Frequent Use of Zolpidem or Zopiclone (Alone and in Combination) and the Risk of Injurious Road Traffic Crashes in Older Adult Drivers: A Population-Based Case–Control and Case-Crossover Study. CNS Drugs 31:8, pages 711-722.
Crossref
Crossref
Yong Lin, Wai Kwong Tang, Hua Jun Liang, Alan Tang & Gabor S. Ungvari. (2016) Psychiatric Morbidity in Dependent Z-Drugs and Benzodiazepine Users. International Journal of Mental Health and Addiction 15:3, pages 555-564.
Crossref
Crossref
D. Riemann, E. Baum, S. Cohrs, T. Crönlein, G. Hajak, E. Hertenstein, P. Klose, J. Langhorst, G. Mayer, C. Nissen, T. Pollmächer, S. Rabstein, A. Schlarb, H. Sitter, H.-G. Weeß, T. Wetter & K. Spiegelhalder. (2017) S3-Leitlinie Nicht erholsamer Schlaf/SchlafstörungenS3 Guidelines on non-restorative sleep/sleep disorders. Somnologie 21:1, pages 2-44.
Crossref
Crossref
Taro Kishi, Shinji Matsunaga & Nakao Iwata. (2016) Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials. European Archives of Psychiatry and Clinical Neuroscience 267:2, pages 149-161.
Crossref
Crossref
StutiJ Jaiswal, RobertL Owens & Atul Malhotra. (2017) Raising awareness about sleep disorders. Lung India 34:3, pages 262.
Crossref
Crossref
Jennifer L. Schroeck, James Ford, Erin L. Conway, Kari E. Kurtzhalts, Megan E. Gee, Krista A. Vollmer & Kari A. Mergenhagen. (2016) Review of Safety and Efficacy of Sleep Medicines in Older Adults. Clinical Therapeutics 38:11, pages 2340-2372.
Crossref
Crossref
F. Paille & A. Maheut-Bosser. (2016) Benzodiazépines et personnes âgées. NPG Neurologie - Psychiatrie - Gériatrie 16:95, pages 246-257.
Crossref
Crossref
Max Tsai, Lambros Chrones, Jinhui Xie, Hakop Gevorkyan & Thomas A. Macek. (2016) A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor. Psychopharmacology 233:21-22, pages 3787-3795.
Crossref
Crossref
J. Pantel. (2016) Neurokognitive Störungen im AlterNeurocognitive disorders in old age. Der Internist 57:10, pages 1029-1036.
Crossref
Crossref
Willy Gomm, Klaus von Holt, Friederike Thomé, Karl Broich, Wolfgang Maier, Klaus Weckbecker, Anne Fink, Gabriele Doblhammer & Britta Haenisch. (2016) Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data. Journal of Alzheimer's Disease 54:2, pages 801-808.
Crossref
Crossref
Robert W. Gould, Michael T. Nedelcovych, Xuewen Gong, Erica Tsai, Michael Bubser, Thomas M. Bridges, Michael R. Wood, Mark E. Duggan, Nicholas J. Brandon, John Dunlop, Michael W. Wood, Magnus Ivarsson, Meredith J. Noetzel, J. Scott Daniels, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn & Carrie K. Jones. (2016) State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 – Relation to antipsychotic-like drug effects. Neuropharmacology 102, pages 244-253.
Crossref
Crossref
Elizabeth K. Stranks & Simon F. Crowe. (2016) The Cognitive Effects of Obstructive Sleep Apnea: An Updated Meta-analysis. Archives of Clinical Neuropsychology, pages acv087.
Crossref
Crossref
Daniel F. Kripke. (2018) Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Research 5, pages 918.
Crossref
Crossref
Ken Inada. (2016) Knowledge regarding Proper Use Guidelines for Benzodiazepinesベンゾジアゼピン系薬物の適正使用のために薬剤師の方へお伝えしたいこと. YAKUGAKU ZASSHI 136:1, pages 73-77.
Crossref
Crossref
Vincent F. Capaldi, Jessica R. Kim, Antigone A. Grillakis, Maura R. Taylor & Carla M. York. (2015) Insomnia in the Military: Application and Effectiveness of Cognitive and Pharmacologic Therapies. Current Psychiatry Reports 17:10.
Crossref
Crossref
Hsin-I Shih, Che-Chen Lin, Yi-Fang Tu, Chia-Ming Chang, Hsiang-Chin Hsu, Chih-Hsien Chi & Chia-Hung Kao. (2015) An Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population. Medicine 94:17, pages e809.
Crossref
Crossref
Michele L. Okun, Rebecca Ebert & Bandana Saini. (2015) A review of sleep-promoting medications used in pregnancy. American Journal of Obstetrics and Gynecology 212:4, pages 428-441.
Crossref
Crossref